tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Repligen Corporation Reports Strong Q2 2025 Growth
PremiumCompany AnnouncementsRepligen Corporation Reports Strong Q2 2025 Growth
1M ago
Repligen’s Strong Organic Growth and Strategic Positioning Make it a Compelling Buy
Premium
Ratings
Repligen’s Strong Organic Growth and Strategic Positioning Make it a Compelling Buy
1M ago
Repligen’s Strong Q2 Performance and Growth Prospects Justify Buy Rating
Premium
Ratings
Repligen’s Strong Q2 Performance and Growth Prospects Justify Buy Rating
1M ago
Repligen resumed with an Overweight at Stephens
PremiumThe FlyRepligen resumed with an Overweight at Stephens
1M ago
Repligen initiated with an Overweight at Barclays
Premium
The Fly
Repligen initiated with an Overweight at Barclays
2M ago
Regeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints
Premium
Market News
Regeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints
3M ago
Repligen’s Fair Valuation and Cautious Growth Outlook Lead to Hold Rating
PremiumRatingsRepligen’s Fair Valuation and Cautious Growth Outlook Lead to Hold Rating
4M ago
Repligen Reports Strong Q1 2025 Financial Results
Premium
Company Announcements
Repligen Reports Strong Q1 2025 Financial Results
4M ago
Repligen’s Earnings Call Highlights Robust Growth and Strategic Moves
Premium
Company Announcements
Repligen’s Earnings Call Highlights Robust Growth and Strategic Moves
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100